Home / Going-concern warnings / ACRO BIOMEDICAL CO., LTD.
Filed 2025-07-11 路 Form 10-Q 路 Accession 0001640334-25-001169 nano
Price before filing: $0.0007 (2025-07-10 close, split/dividend-adjusted)
Market cap at flag: $42,029 (2025-07-11) 路 Latest: $1.6M (2026-10-12)
| Window | ACBM | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +0.0% | +1.6% | -1.6% | 2025-08-11 |
| 90 days | +0.0% | +7.5% | -7.5% | 2025-10-09 |
| 180 days | +3071.4% | +10.8% | +3060.6% | 2026-01-07 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2023-09-30)
Why this score: quarterly (unaudited) disclosure; also within 90 days: Auditor change
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.